美国 · SEC FORM 4
ADIAL PHARMACEUTICALS, INC.
ADIL · Nasdaq · CIK 0001513525 · Healthcare · Biotechnology
内部人信号
1 位买方 · 5 条买入交易行 · $106.3K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 41.2
- 41.1
- 41.0
- 41.0
- 40.9
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -34.7%
- 3M
- +49.5%
- 6M
- +148.6%
- 12M
- -56.5%
波动率与流动性
- 波动率
- 118.6%
- Beta
- 1.50
- 平均每日成交额
- USD 247,806
估值
- 市值
- USD 11.4M
- P/E
- —
基本面
- 利润率
- 0.0%
- ROE
- -151184385.1%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-05 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：ROE · 财年截止日：2025-12-31 · 来自 Yahoo Finance：市值, 利润率 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 183,323
- 上期报告
- 209,983
- 日均成交量
- 42,787
- 回补天数
- 4.3
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Coastlands Capital LP | 买入 (P) | Common Stock | 1,233 | USD 2.75 | USD 3,391 | SEC 申报 ↗ |
| 2026-07-14 | Coastlands Capital LP | 买入 (P) | Common Stock | 2,000 | USD 2.65 | USD 5,300 | SEC 申报 ↗ |
| 2026-07-10 | Coastlands Capital LP | 买入 (P) | Common Stock | 1,700 | USD 2.70 | USD 4,590 | SEC 申报 ↗ |
| 2026-07-09 | Coastlands Capital LP | 买入 (P) | Common Stock | 10,053 | USD 2.79 | USD 28,048 | SEC 申报 ↗ |
| 2026-06-29 | Coastlands Capital LP | 买入 (P) | Common Stock | 25,000 | USD 2.60 | USD 65,000 | SEC 申报 ↗ |
| 2023-09-29 | Schuyler Kevin | 买入 (P) | Common Stock | 700 | USD 2.74 | USD 1,918 | SEC 申报 ↗ |
| 2021-12-30 | Newman James W. Jr. | 买入 (P) | Common Stock | 25,000 | USD 2.69 | USD 67,300 | SEC 申报 ↗ |
| 2021-11-30 | Stilley William B. III | 买入 (P) | Common Stock | 10,600 | USD 2.75 | USD 29,150 | SEC 申报 ↗ |
| 2021-11-29 | Stilley William B. III | 买入 (P) | Common Stock | 10,000 | USD 2.59 | USD 25,900 | SEC 申报 ↗ |
| 2021-11-26 | Newman James W. Jr. | 买入 (P) | Common Stock | 10,000 | USD 2.85 | USD 28,500 | SEC 申报 ↗ |
| 2020-03-27 | Newman James W. Jr. | 买入 (P) | Common Stock | 19,644 | USD 1.36 | USD 26,769 | SEC 申报 ↗ |
| 2020-03-26 | Stilley William B. III | 买入 (P) | Common Stock | 12,652 | USD 1.47 | USD 18,598 | SEC 申报 ↗ |
| 2020-03-25 | Stilley William B. III | 买入 (P) | Common Stock | 12,348 | USD 1.13 | USD 13,953 | SEC 申报 ↗ |
Form 4 申报证据
15 transaction lines in the latest 365-day window; 44 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Coastlands Capital LP | 买入 (P) | Common Stock | 1,233 | USD 2.75 | USD 3,391 | SEC 申报 ↗ |
| 2026-07-14 | Coastlands Capital LP | 买入 (P) | Common Stock | 2,000 | USD 2.65 | USD 5,300 | SEC 申报 ↗ |
| 2026-07-10 | Coastlands Capital LP | 买入 (P) | Common Stock | 1,700 | USD 2.70 | USD 4,590 | SEC 申报 ↗ |
展开近期 Form 4 证据 (13 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Coastlands Capital LP | 买入 (P) | Common Stock | 1,233 | USD 2.75 | USD 3,391 | SEC 申报 ↗ |
| 2026-07-14 | Coastlands Capital LP | 买入 (P) | Common Stock | 2,000 | USD 2.65 | USD 5,300 | SEC 申报 ↗ |
| 2026-07-10 | Coastlands Capital LP | 买入 (P) | Common Stock | 1,700 | USD 2.70 | USD 4,590 | SEC 申报 ↗ |
| 2026-07-09 | Coastlands Capital LP | 买入 (P) | Common Stock | 10,053 | USD 2.79 | USD 28,048 | SEC 申报 ↗ |
| 2026-06-29 | Coastlands Capital LP | 买入 (P) | Common Stock | 25,000 | USD 2.60 | USD 65,000 | SEC 申报 ↗ |
| 2026-06-12 | Davidson Matt | 奖励／授予 (A) | Common Stock | 232,417 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Davidson Matt | 奖励／授予 (A) | Series A Preferred Stock | 1,923 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-11 | Davidson Matt | 奖励／授予 (A) | Common Stock | 65,074 | USD — | USD — | SEC 申报 ↗ |
| 2026-04-07 | Shah Vinay | 奖励／授予 (A) | Common Stock | 17,325 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-07 | Schuyler Kevin | 奖励／授予 (A) | Common Stock | 9,185 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-07 | Goodman Tony | 奖励／授予 (A) | Common Stock | 26,510 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-07 | Gilliland Robertson H. | 奖励／授予 (A) | Common Stock | 9,185 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-07 | Claiborne Cary J | 奖励／授予 (A) | Common Stock | 37,985 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ADIL |
| CIK | 0001513525 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 44 transaction lines from 2020-03-03 to 2026-07-16 17 P purchase lines · 3 S sale lines · 24 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.